In conclusion, we demonstrate that compound heterozygous FARS2 mutations lead to an early-onset mitochondrial disease phenotype associated with respiratory chain dysfunction and characterised by infantile spasms that evolved into refractory focal epilepsy, neurodevelopmental regression and the development of subcortical white matter abnormalities on cranial MRI. This evidence concerns the gene FARS2 and mitochondrial disease.